What they do

ZBeats offers FDA-cleared cloud-based ECG analysis via its ZBPro Diagnostic platform. Designed for retrospective Holter ECG interpretation, the solution integrates clinical expertise with intelligent automation to deliver rapid, standardized, and clinician-validated reports. ZBeats supports industry ECG formats (EDF, MIT-BIH, ISHNE) and enables device-agnostic, browser-accessible workflows at consumer-scale efficiency.

The platform combines clinical expertise with intelligent automation to deliver fast, validated reports clinicians can trust, streamlined workflows for rapid rhythm review, and clinical-grade outputs at consumer-scale efficiency through secure, cloud-native diagnostics.

Why we invested

Strong founder-market fit with deep healthcare technology expertise and proven regulatory navigation capabilities. The company addresses a critical need in cardiology with technology that is expected to receive FDA clearance by that time, enabling scalable clinical expertise through intelligent automation and positioning it strongly in the growing digital health diagnostics market.

Key Features

• ● Clinical-Grade Accuracy: Powered by physician-validated algorithms to ensure reliable, diagnostic-quality interpretations.
• ● Cloud-Native & API-Ready: Accessible via browser with seamless API integration for flexible deployment and scaling.
• ● Device-Agnostic Compatibility: Supports ECG recordings from a wide range of third-party devices and standard file formats.
• ● Scalable & Efficient: Delivers rapid, standardized ECG reports with clinical-grade precision at consumer-scale throughput.
• ● FDA 510(k) Cleared: ZBPro Diagnostic meets regulatory and clinical benchmarks for arrhythmia analysis, including AFib.